vimarsana.com

Latest Breaking News On - Roberte funck - Page 2 : vimarsana.com

Creative Planning Sells 54,250 Shares of Abbott Laboratories (NYSE:ABT)

Creative Planning trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 751,772 shares of the healthcare product maker’s stock after selling 54,250 shares during the quarter. Creative Planning’s holdings in Abbott Laboratories […]

Abbott Laboratories (NYSE:ABT) Shares Sold by Mairs & Power Inc

Mairs & Power Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% in the fourth quarter, Holdings Channel reports. The firm owned 1,285,461 shares of the healthcare product maker’s stock after selling 13,538 shares during the quarter. Abbott Laboratories accounts for 1.5% of Mairs & Power Inc.’s holdings, making the stock […]

Abbott Laboratories (NYSE:ABT) Stock Position Lifted by Humankind Investments LLC

Humankind Investments LLC increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.1% during the fourth quarter, Holdings Channel reports. The firm owned 4,404 shares of the healthcare product maker’s stock after purchasing an additional 131 shares during the period. Humankind Investments LLC’s holdings in Abbott Laboratories were worth $485,000 at the end […]

Vontobel Asset Management Inc Has $714 58 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)

Vontobel Asset Management Inc. increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 11.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,163,414 shares of the healthcare product maker’s stock after purchasing an additional 625,670 shares during the period. Abbott […]

Vontobel Asset Management Inc Has $714 58 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)

Vontobel Asset Management Inc. increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 11.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,163,414 shares of the healthcare product maker’s stock after purchasing an additional 625,670 shares during the period. Abbott […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.